Target (CBDY) Non-Current Assets (2014 - 2026)
Target (CBDY) reported Non-Current Assets of $3.6 million for Q1 2026, down 15.53% year-over-year from $4.3 million in Q1 2025, and down 6.57% quarter-over-quarter from $3.8 million in Q4 2025.
Target (CBDY) Non-Current Assets (2014 - 2026) Analysis & Trends
Target (CBDY) has 12 years of Non-Current Assets data on file, last reported at $3.6 million in Q1 2026.
- Non-Current Assets for Q1 2026 came in at $3.6 million, down 15.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.6 million (down 15.53% YoY), and the FY2025 annual result was $3.8 million, down 13.96% from the prior year.
- Non-Current Assets retreated to $3.6 million in Q1 2026 per CBDY's latest filing, from $3.8 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $12.6 million in Q1 2022 and troughed at $3.6 million in Q1 2026.
- A 5-year average of $6.1 million and a median of $5.4 million in 2024 frame the typical range for Non-Current Assets.
- On a YoY basis, Non-Current Assets climbed as much as 2.73% in 2022 and fell as far as 46.66% in 2022.
- A 5-year view of Non-Current Assets shows it stood at $6.7 million in 2022, then dropped by 13.66% to $5.7 million in 2023, then slipped by 22.19% to $4.5 million in 2024, then retreated by 13.96% to $3.8 million in 2025, then retreated by 6.57% to $3.6 million in 2026.
- Business Quant data shows CBDY's Non-Current Assets at $3.6 million in Q1 2026, $3.8 million in Q4 2025, and $4.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | Target | - | - | 191,787.00 | 3.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.59 Mn |
| Dec 31, 2025 | 3.85 Mn |
| Sep 30, 2025 | 4.02 Mn |
| Jun 30, 2025 | 4.28 Mn |
| Mar 31, 2025 | 4.26 Mn |
| Dec 31, 2024 | 4.47 Mn |
| Sep 30, 2024 | 4.99 Mn |
| Jun 30, 2024 | 5.12 Mn |
| Mar 31, 2024 | 5.38 Mn |
| Dec 31, 2023 | 5.75 Mn |
| Sep 30, 2023 | 5.74 Mn |
| Jun 30, 2023 | 6.10 Mn |
| Mar 31, 2023 | 6.94 Mn |
| Dec 31, 2022 | 6.66 Mn |
| Sep 30, 2022 | 9.74 Mn |
| Jun 30, 2022 | 10.65 Mn |
| Mar 31, 2022 | 12.61 Mn |
| Dec 31, 2021 | 12.48 Mn |
| Sep 30, 2021 | 12.44 Mn |
| Jun 30, 2021 | 12.96 Mn |